A 52-year-old male presents to the transplant nephrology clinic for evaluation of a low-grade fever and a significant decrease in his daily urine output. He received a living-donor kidney transplant one month ago. His vital signs are stable, but physical examination reveals mild tenderness over the allograft site in the right lower quadrant. Recent laboratory tests show an acute elevation in his serum creatinine from a baseline of 1.3 mg/dL to 2.9 mg/dL. Arrange the following clinical steps in the optimal sequence to diagnose and manage his suspected acute cellular rejection.
- 1Perform a Doppler ultrasound of the renal allograft
- 2Obtain a percutaneous renal allograft biopsy
- 3Initiate high-dose intravenous methylprednisolone
- 4Administer anti-thymocyte globulin therapy
Answer
The correct sequence is to first perform a Doppler ultrasound, followed by a renal allograft biopsy, then initiate high-dose intravenous methylprednisolone, and finally administer anti-thymocyte globulin if the rejection is steroid-resistant.
The standard sequence for evaluating and managing acute renal allograft dysfunction begins with non-invasive imaging. A Doppler ultrasound rules out structural, vascular, or obstructive complications. Once these are ruled out, a percutaneous biopsy is performed to confirm the diagnosis of acute cellular rejection and rule out other pathologies. The first-line medical intervention is high-dose intravenous corticosteroids. If the rejection is severe or does not respond to corticosteroids (steroid-resistant), second-line therapy with lymphocyte-depleting antibodies is indicated.
Step-by-Step Solution
Key Concept
Management of acute renal allograft rejection